Results 181 to 190 of about 57,036 (277)

Raw citrus by‐product valorization: unlocking the potential of biotransformation by Talaromyces amestolkiae to obtain cellulolytic enzymes and natural colorants

open access: yesBiofuels, Bioproducts and Biorefining, Volume 20, Issue 2, Page 806-816, March/April 2026.
Abstract Agro‐industrial by‐products can be used as valuable nutrient sources for the sustainable production of high‐value‐added compounds. The goal of this study was utilize raw citrus industrial by‐product (RCB) as a carbon source for the simultaneous production of red colorants and enzymes by the filamentous fungus Talaromyces amestolkiae under lab ...
Caio de Azevedo Lima   +8 more
wiley   +1 more source

Prenatal and postnatal atrazine-induced endocrine and ovarian chemical biotransformation protein disruption in offspring. [PDF]

open access: yesJ Endocr Soc
Adeyanju O   +5 more
europepmc   +1 more source

Targeting Autophagy in Ovarian Cancer: The Emerging Role of Ginsenosides

open access: yesCancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Ovarian cancer, the third most prevalent gynecological malignancy, is frequently diagnosed at an advanced stage owing to its asymptomatic early progression. Despite the application of conventional therapies, clinical management remains limited by adverse effects and the development of drug resistance.
Yuxin Guo   +4 more
wiley   +1 more source

Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes. [PDF]

open access: yesNat Microbiol
Zhang L   +10 more
europepmc   +1 more source

Substrate Scope Expansion of Tryptophan Synthase for the Chemo‐Enzymatic Synthesis of Non‐Canonical Tryptophans

open access: yesChemCatChem, Volume 18, Issue 5, 13 March 2026.
The substrate scope of tryptophan synthase from Salmonella enterica (SeTrpS) was probed against 28 synthetic indole derivatives bearing aryl rings, N‐methylamino groups, alkynes, and halogens, accessing a broad range of nonnatural l‐tryptophans on analytical scale.
Celeste Nobbio   +6 more
wiley   +1 more source

Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of [14C]Xevinapant, a Potent, Oral, Small‐Molecule IAP Inhibitor

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 3, March 2026.
Abstract This Phase 1, open‐label, 2‐part, single‐dose study aimed to investigate the pharmacokinetics, metabolism, and excretion of xevinapant, a small molecule inhibitor of apoptosis proteins (IAPs), in healthy male subjects. Part 1 focused on determining the mass balance recovery, pharmacokinetics, and metabolic profile of [14C]xevinapant following ...
Annick Menetrey   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy